Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)
2020
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI